Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Malignant Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01840280
What this trial is testing

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 324
Not applicableStudy completedNCT05242562
What this trial is testing

Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life

Who this might be right for
Colorectal CancerColonic Polyp
Radboud University Medical Center 509
Not applicableUnknownNCT04404673
What this trial is testing

Urinary and Sexual Dysfunctions Evaluation After Rectal Resection

Who this might be right for
Rectal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,172
Post-approval studies (Phase 4)UnknownNCT04269369
What this trial is testing

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Who this might be right for
Colon CancerStomach TumorAnal Tumor+2 more
Jessa Hospital 250
Large-scale testing (Phase 3)Study completedNCT02273141
What this trial is testing

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

Who this might be right for
Colorectal CancerColorectal CarcinomaColon Cleansing
Norgine 515
Testing effectiveness (Phase 2)WithdrawnNCT03272659
What this trial is testing

The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics

Who this might be right for
Colorectal CancerPhotodynamic Diagnosis
Dr. Te Vuong
Testing effectiveness (Phase 2)Study completedNCT01554059
What this trial is testing

Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients

Who this might be right for
Rectal Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07562659
What this trial is testing

Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer

Who this might be right for
ctDNAColorectal Cancer (CRC)Adjuvant Chemotherapy
Fudan University 80
Not applicableActive Not RecruitingNCT03637686
What this trial is testing

IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Aarhus 3,182
Not applicableStudy completedNCT03133286
What this trial is testing

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Who this might be right for
Radiation TherapyCancerCancer of Anus+16 more
DxTerity Diagnostics 16
Not applicableLooking for participantsNCT07192055
What this trial is testing

Self-sampling to Optimize Anal Lesion Outcomes

Who this might be right for
Anal Cancer
Medical College of Wisconsin 572
Not applicableStudy completedNCT05934643
What this trial is testing

An Observational Cohort Study to Assess the Postop Activity of Colorectal Patients Undergoing Elective Surgery (PHYSPAL)

Who this might be right for
Colorectal (Colon or Rectal) Cancer
University of Nottingham 17
Large-scale testing (Phase 3)Study completedNCT00911391
What this trial is testing

Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy

Who this might be right for
Colorectal CancerColectomySurgery+1 more
University of Auckland, New Zealand 85
Not applicableStudy completedNCT03828318
What this trial is testing

Impact of a Patient-Centered Program for Low Anterior Resection Syndrome a Multicenter Randomized Controlled Trial

Who this might be right for
Rectal CancerSurgeryPatient Activation+2 more
Jewish General Hospital 160
Early research (Phase 1)Study completedNCT00497497
What this trial is testing

PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00636610
What this trial is testing

Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 199
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Not applicableStudy completedNCT00442520
What this trial is testing

Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

Who this might be right for
Lung CancerColorectal CancerHead and Neck Cancer
University of Kansas Medical Center 70
Not applicableUnknownNCT05354882
What this trial is testing

Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology

Who this might be right for
Breast CancerColo-rectal CancerLung Cancer+1 more
Université Sorbonne Paris Nord 150
Testing effectiveness (Phase 2)Study completedNCT00191984
What this trial is testing

The Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Eli Lilly and Company 46
Next Page